Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    February 2017
  1. RYU SH, Heo SH, Park EY, Choi KC, et al
    Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes.
    Anticancer Res. 2017;37:607-614.
    PubMed     Text format     Abstract available


    January 2017
  2. SEHMISCH L, Schild SE, Rades D
    Development of a Survival Score for Patients with Cerebral Metastases from Melanoma.
    Anticancer Res. 2017;37:249-252.
    PubMed     Text format     Abstract available


  3. FORTIS SP, Anastasopoulou EA, Voutsas IF, Baxevanis CN, et al
    Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma.
    Anticancer Res. 2017;37:143-148.
    PubMed     Text format     Abstract available


  4. NGUYEN AH, Detty SQ, Agrawal DK
    Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Anticancer Res. 2017;37:1-7.
    PubMed     Text format     Abstract available


    December 2016
  5. RADES D, Sehmisch L, Janssen S, Schild SE, et al
    Prognostic Factors After Whole-brain Radiotherapy Alone for Brain Metastases from Malignant Melanoma.
    Anticancer Res. 2016;36:6637-6640.
    PubMed     Text format     Abstract available


  6. NAFFOUJE SA, Naffouje R, Chen J, Salti GI, et al
    Validation and Enhancement of the Clinicopathological Melanoma Nomogram via Incorporation of a Molecular Marker in the Primary Tumor.
    Anticancer Res. 2016;36:6603-6610.
    PubMed     Text format     Abstract available


  7. SOLARI N, Gipponi M, Franco DS, Re F, et al
    Videoscopic Inguinal-iliac-obturator Lymph-node Dissection: New Videoscopic Technique for Regional Lymphadenectomy in Patients with Melanoma.
    Anticancer Res. 2016;36:6579-6583.
    PubMed     Text format     Abstract available


  8. YAN S, Holderness BM, Li Z, Seidel GD, et al
    Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
    Anticancer Res. 2016;36:6449-6456.
    PubMed     Text format     Abstract available


  9. MANTSO T, Sfakianos AP, Atkinson A, Anestopoulos I, et al
    Development of a Novel Experimental In Vitro Model of Isothiocyanate-induced Apoptosis in Human Malignant Melanoma Cells.
    Anticancer Res. 2016;36:6303-6309.
    PubMed     Text format     Abstract available


    November 2016
  10. MARTON A, Kusz E, Kolozsi C, Tubak V, et al
    Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFkB Activation and Suppress Growth of A375 Human Melanoma.
    Anticancer Res. 2016;36:5743-5750.
    PubMed     Text format     Abstract available


    October 2016
  11. SHAVERDIAN N, Wang J, Levin-Epstein R, Schaue D, et al
    Pro-inflammatory State Portends Poor Outcomes with Stereotactic Radiosurgery for Brain Metastases.
    Anticancer Res. 2016;36:5333-5337.
    PubMed     Text format     Abstract available


    September 2016
  12. BASNET A, Saad N, Benjamin S
    A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.
    Anticancer Res. 2016;36:4795-8.
    PubMed     Text format     Abstract available


  13. DONIZY P, Biecek P, Halon A, Matkowski R, et al
    BILLCD8 - A Multivariable Survival Model as a Simple and Clinically Useful Prognostic Tool to Identify High-risk Cutaneous Melanoma Patients.
    Anticancer Res. 2016;36:4739-47.
    PubMed     Text format     Abstract available


  14. RAICA M, Jitariu AA, Cimpean AM
    Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma.
    Anticancer Res. 2016;36:4427-35.
    PubMed     Text format     Abstract available


    August 2016

  15. Melanoma.
    Anticancer Res. 2016;36:4377.
    PubMed     Text format    



  16. Genetics of Melanoma.
    Anticancer Res. 2016;36:4374.
    PubMed     Text format    


    July 2016
  17. LUO H, Umebayashi M, Doi K, Morisaki T, et al
    Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma Cells.
    Anticancer Res. 2016;36:3585-9.
    PubMed     Text format     Abstract available


  18. CALIK J, Pula B, Piotrowska A, Wojnar A, et al
    Prognostic Significance of NOGO-A/B and NOGO-B Receptor Expression in Malignant Melanoma - A Preliminary Study.
    Anticancer Res. 2016;36:3401-7.
    PubMed     Text format     Abstract available


  19. TANG T, Eldabaje R, Yang L
    Current Status of Biological Therapies for the Treatment of Metastatic Melanoma.
    Anticancer Res. 2016;36:3229-41.
    PubMed     Text format     Abstract available


  20. SAMARA P, Skopeliti M, Tsiatas ML, Georgaki S, et al
    A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer.
    Anticancer Res. 2016;36:3373-82.
    PubMed     Text format     Abstract available


  21. YAMASHITA K, Hasegawa H, Fujita M, Nishi M, et al
    Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer.
    Anticancer Res. 2016;36:3659-65.
    PubMed     Text format     Abstract available


    June 2016
  22. GORKA E, Fabo D, Gezsi A, Czirbesz K, et al
    Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in Melanoma.
    Anticancer Res. 2016;36:3065-9.
    PubMed     Text format     Abstract available


  23. YAN S, Coffing BN, Li Z, Xie H, et al
    Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.
    Anticancer Res. 2016;36:2871-80.
    PubMed     Text format     Abstract available


    May 2016
  24. ORNAT M, Kobierzycki C, Grzegrzolka J, Pula B, et al
    SOX18 Expression in Non-melanoma Skin Cancer.
    Anticancer Res. 2016;36:2379-83.
    PubMed     Text format     Abstract available


  25. ESPELI V, Ruegg E, Hottinger AF, Modarressi A, et al
    Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
    Anticancer Res. 2016;36:2359-64.
    PubMed     Text format     Abstract available


  26. KIM JK, Kang KA, Ryu YS, Piao MJ, et al
    Induction of Endoplasmic Reticulum Stress via Reactive Oxygen Species Mediated by Luteolin in Melanoma Cells.
    Anticancer Res. 2016;36:2281-9.
    PubMed     Text format     Abstract available


    April 2016
  27. WOJCIECHOWSKA-ZDROJOWY M, Szepietowski JC, Matusiak L, Dziegiel P, et al
    Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
    Anticancer Res. 2016;36:1591-7.
    PubMed     Text format     Abstract available


  28. HINTSALA HR, Jokinen E, Haapasaari KM, Moza M, et al
    Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
    Anticancer Res. 2016;36:1497-506.
    PubMed     Text format     Abstract available


    January 2016
  29. ADAMS S, Lin J, Brown D, Shriver CD, et al
    Ultraviolet Radiation Exposure and the Incidence of Oral, Pharyngeal and Cervical Cancer and Melanoma: An Analysis of the SEER Data.
    Anticancer Res. 2016;36:233-7.
    PubMed     Text format     Abstract available


    December 2015
  30. DECOSTER L, Vande Broek I, Neyns B, Majois F, et al
    Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.
    Anticancer Res. 2015;35:6893-9.
    PubMed     Text format     Abstract available


  31. BARAK V, Leibovici V, Peretz T, Kalichman I, et al
    Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100beta.
    Anticancer Res. 2015;35:6755-60.
    PubMed     Text format     Abstract available


    November 2015
  32. KRAJSOVA I, Arenberger P, Lakomy R, Kubala E, et al
    Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma.
    Anticancer Res. 2015;35:6303-10.
    PubMed     Text format     Abstract available


  33. HU WP, Hsu CC, Wang YC, Senadi GC, et al
    Bis(phenylidenebenzeneamine)-1-disulfide Derivatives Induce Autophagy in Melanoma Cells Through a Mitochondria-mediated Pathway.
    Anticancer Res. 2015;35:6075-80.
    PubMed     Text format     Abstract available


    October 2015
  34. PAP M, Bator J, Szeberenyi J
    Sensitivity of Human Malignant Melanoma Cell Lines to Newcastle Disease Virus.
    Anticancer Res. 2015;35:5401-6.
    PubMed     Text format     Abstract available


  35. PROVINCIALI M, Pierpaoli E, Bartozzi B, Bernardini G, et al
    Zinc Induces Apoptosis of Human Melanoma Cells, Increasing Reactive Oxygen Species, p53 and FAS Ligand.
    Anticancer Res. 2015;35:5309-16.
    PubMed     Text format     Abstract available


  36. VETVICKA V, Vetvickova J
    Glucan Supplementation Has Strong Anti-melanoma Effects: Role of NK Cells.
    Anticancer Res. 2015;35:5287-92.
    PubMed     Text format     Abstract available


    September 2015
  37. HAN SM, Park CW, Ahn JO, Park SC, et al
    Pro-apoptotic and Growth-inhibitory Effect of IFN-beta-Overexpressing Canine Adipose Tissue-derived Mesenchymal Stem Cells Against Melanoma Cells.
    Anticancer Res. 2015;35:4749-56.
    PubMed     Text format     Abstract available


    August 2015
  38. OTSUBO D, Yamashita K, Fujita M, Nishi M, et al
    Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation.
    Anticancer Res. 2015;35:4425-31.
    PubMed     Text format     Abstract available


    July 2015
  39. ZHANG L, Agarwal S, Shohet JM, Zage PE, et al
    CD114 Expression Mediates Melanoma Tumor Cell Growth and Treatment Resistance.
    Anticancer Res. 2015;35:3787-92.
    PubMed     Text format     Abstract available


  40. ADINOLFI B, Carpi S, Romanini A, DA Pozzo E, et al
    Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells.
    Anticancer Res. 2015;35:3781-6.
    PubMed     Text format     Abstract available


    June 2015
  41. KUCERA R, Topolcan O, Treskova I, Kinkorova J, et al
    Evaluation of IL-2, IL-6, IL-8 and IL-10 in Malignant Melanoma Diagnostics.
    Anticancer Res. 2015;35:3537-41.
    PubMed     Text format     Abstract available


  42. ZHANG L, Xie Q, Shan SJ, Tabor MK, et al
    Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.
    Anticancer Res. 2015;35:3185-91.
    PubMed     Text format     Abstract available


    May 2015

  43. BRAF Targets in Melanoma. Biological Mechanisms, Resistance, and Drug Delivery.
    Anticancer Res. 2015;35:3113.
    PubMed     Text format    


  44. WOZNIAK M, Sztiller-Sikorska M, Czyz M
    Expression of miRNAs as Important Element of Melanoma Cell Plasticity in Response to Microenvironmental Stimuli.
    Anticancer Res. 2015;35:2747-58.
    PubMed     Text format     Abstract available


    April 2015
  45. SIMONETTI O, Lucarini G, Rubini C, Lazzarini R, et al
    Clinical and Prognostic Significance of Survivin, AKT and VEGF in Primary Mucosal Oral Melanoma.
    Anticancer Res. 2015;35:2113-20.
    PubMed     Text format     Abstract available


  46. POCHEC E, Bubka M, Rydlewska M, Janik M, et al
    Aberrant Glycosylation of alphavbeta3 Integrin is Associated with Melanoma Progression.
    Anticancer Res. 2015;35:2093-103.
    PubMed     Text format     Abstract available


    March 2015
  47. DRUEPPEL D, Schultheis B, Solass W, Ergonenc H, et al
    Primary malignant melanoma of the breast: case report and review of the literature.
    Anticancer Res. 2015;35:1709-13.
    PubMed     Text format     Abstract available


  48. JAVAID S, Terai K, Dudek AZ
    Chondroitin Sulfate Proteoglycan-4 Does Not Protect Melanoma Cells During Inhibition of PI3K and mTOR Pathways.
    Anticancer Res. 2015;35:1279-84.
    PubMed     Text format     Abstract available


    February 2015

  49. Pathology of melanocytic nevi and melanoma. Third edition.
    Anticancer Res. 2015;35:1224.
    PubMed     Text format    


  50. LINARDOU H, Pentheroudakis G, Varthalitis I, Gogas H, et al
    Predictive Biomarkers to Chemotherapy in Patients with Advanced Melanoma Receiving the Combination of Cisplatin - Vinblastine - Temozolomide (PVT) as First-line Treatment: A Study of the Hellenic Cooperative Oncology Group (HECOG).
    Anticancer Res. 2015;35:1105-13.
    PubMed     Text format     Abstract available


  51. JI BC, Hsiao YP, Tsai CH, Chang SJ, et al
    Cantharidin Impairs Cell Migration and Invasion of A375.S2 Human Melanoma Cells by Suppressing MMP-2 and -9 Through PI3K/NF-kappaB Signaling Pathways.
    Anticancer Res. 2015;35:729-38.
    PubMed     Text format     Abstract available


    January 2015
  52. RAMOS D, Pellin-Carcelen A, Agusti J, Murgui A, et al
    Deregulation of glyceraldehyde-3-phosphate dehydrogenase expression during tumor progression of human cutaneous melanoma.
    Anticancer Res. 2015;35:439-44.
    PubMed     Text format     Abstract available


  53. DONIZY P, Kaczorowski M, Halon A, Leskiewicz M, et al
    Paucity of Tumor-infiltrating Lymphocytes Is an Unfavorable Prognosticator and Predicts Lymph Node Metastases in Cutaneous Melanoma Patients.
    Anticancer Res. 2015;35:351-8.
    PubMed     Text format     Abstract available


  54. KIM C, Economou S, Amatruda TT, Martin JC, et al
    Prognostic significance of microscopic tumor burden in sentinel lymph node in patients with cutaneous melanoma.
    Anticancer Res. 2015;35:301-9.
    PubMed     Text format     Abstract available


  55. AHN JO, Coh YR, Lee HW, Shin IS, et al
    Human Adipose Tissue-derived Mesenchymal Stem Cells Inhibit Melanoma Growth In Vitro and In Vivo.
    Anticancer Res. 2015;35:159-68.
    PubMed     Text format     Abstract available


  56. LLOYD MC, Szekeres K, Brown JS, Blanck G, et al
    Class II Transactivator Expression in Melanoma Cells Facilitates T-cell Engulfment.
    Anticancer Res. 2015;35:25-9.
    PubMed     Text format     Abstract available


    December 2014
  57. HATANAKA M, Higashi Y, Fukushige T, Baba N, et al
    Cleaved CD147 Shed from the Surface of Malignant Melanoma Cells Activates MMP2 Produced by Fibroblasts.
    Anticancer Res. 2014;34:7091-6.
    PubMed     Text format     Abstract available


    November 2014
  58. HAU HM, Tautenhahn HM, Schoenberg MB, Atanasov G, et al
    Liver resection in multimodal concepts improves survival of metastatic melanoma: a single-centre case-matched control study.
    Anticancer Res. 2014;34:6633-9.
    PubMed     Text format     Abstract available


    September 2014
  59. OELKRUG C, Lange CM, Wenzel E, Fricke S, et al
    Analysis of the tumoricidal and anti-cachectic potential of curcumin.
    Anticancer Res. 2014;34:4781-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: